Clinical observation on therapeutic effect of cough variance asthma evoked by mycoplasma pneumonia treated by azithromycin combined with inhalation
- VernacularTitle:阿奇霉素联合气雾剂治疗咳嗽变异性哮喘的疗效观察
- Author:
Qi CAI
;
Jinhui LIU
;
Weiben HUANG
;
Dongmei LI
- Publication Type:Journal Article
- Keywords:
Pneumonia,mycoplasma;
Asthma;
Cough;
Drug therapy,combination
- From:
Chinese Journal of Primary Medicine and Pharmacy
2006;0(01):-
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe the curative effect and prognosis of cough variance asthma(CVA) evoked by mycoplasma pneumonia(MP) treated by azithromycin combined with pumicort and bricasol.Methods 126 CVAs evoked by MP were divided randomly into two groups:the therapeutic group,were given azithromycin orally and inhaled pumicort and bricasol,the control group,were treated only by azithromycin orally.The remission rate and recurrence rate of cough between the two groups were compared.Results The remission rate and recurrence rate of cough of therapeutic group were 100% and 15.9% respectively while those of the control group were 28.6% and 60.3% respectively.The difference between two groups was significant.Conclusion Azithromycin combined with pumicort and bricasol can improve significantly the curative effect of CVA evoked by MP,decrease the recurrence and make for the prognosis.
